PATENT CLAIM ANALYSIS

Application Number: 15757177
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "254010"]

Abstract:
The present invention relates to 1-(4-(2-((1-(3,4-difluorophenyl)-1 H-pyrazol-3-yl)methoxy)ethyl)piperazin-1-yl)ethanone salts, specifically to the hydrochloride and to the maleate, to pharmaceutical compositions comprising them, and to their use in therapy and/or prophylaxis of sigma receptor associated diseases.

Claim (Index 25):
The method according to  claim 23  wherein the salt administered to the patient is the hydrochloride salt of 1-(4-(2-((1-(3,4-difluorophenyl)-1H-pyrazol-3-yl)methoxy)ethyl)piperazin1-yl)ethanone.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 90.0
- Lexical Diversity: 1.425
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13699341', '12281313', '13194434', '15128846', '14376307']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7696052433447097
- 35 USC 102 Novelty (BERT): 0.5341532091198695
- Combined Prediction Score: 0.7460600399222257
- Mean Citation Score: 325.414982
- Max Citation Score: 341.91153
- Similarity Product: 250.86254016413207

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test